Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phospholipase A2 enzymes in eicosanoid generation.

C O Bingham1, K F Austen

  • 1Department of Medicine, Harvard Medical School, Boston, MA, USA.

Proceedings of the Association of American Physicians
|December 11, 1999
PubMed
Summary

Phospholipase A2 (PLA2) enzymes are key to releasing arachidonic acid for producing eicosanoids like leukotrienes. This review examines diverse PLA2 enzymes and their regulatory roles in eicosanoid biosynthesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group.

Seminars in arthritis and rheumatism·2023
Same author

Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2018
Same author

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.

Journal for immunotherapy of cancer·2017
Same author

Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers.

Annals of the rheumatic diseases·2016
Same author

Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.

Annals of the rheumatic diseases·2016
Same author

Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.

Arthritis care & research·2015

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Signaling

Background:

  • Phospholipase A2 (PLA2) enzymes hydrolyze esterified fatty acids from glycerophospholipids.
  • Arachidonic acid, a substrate for PLA2, is crucial for generating eicosanoids, including leukotrienes and prostanoids.
  • The PLA2 enzyme family is expanding, with many members potentially regulating eicosanoid biosynthesis.

Purpose of the Study:

  • To review the diverse roles of PLA2 enzymes in arachidonic acid release.
  • To evaluate the function of various PLA2 enzymes in leukotriene and eicosanoid biosynthesis.
  • To discuss regulatory mechanisms controlling cellular PLA2 activity.

Main Methods:

  • Literature review of studies on PLA2 enzymes.
  • Analysis of PLA2 enzyme substrates and products.

Related Experiment Videos

  • Examination of PLA2 enzyme regulation (expression, posttranslational modification, calcium dependence, localization).

    • Main Results:

    • Multiple PLA2 enzymes contribute to arachidonic acid release, potentially acting as rate-limiting steps.
    • PLA2 function is modulated by expression levels, phosphorylation, calcium, and subcellular localization.
    • Secreted PLA2 enzymes can act as autocrine or paracrine mediators via receptor interactions.

    Conclusions:

    • Understanding the diverse PLA2 enzyme family is critical for comprehending eicosanoid biosynthesis.
    • Regulatory mechanisms provide multiple points for controlling inflammatory pathways mediated by eicosanoids.
    • Further research into specific PLA2 isoforms will illuminate their distinct roles in health and disease.